BioWorld MedTech

Sep. 19, 2013

Device China annual conference: Hospital upgrades in China a boon for device companies

As many as three-quarters of Chinese hospitals are expanding or upgrading their infrastructure and this will give medical device companies with the right market reach an enormous opportunity over the next decade or more. Read More

The MDD Interview: Webb says patient selection hasbecome the key to future of TAVI

NeuroStar found to improve QOL in major depressive patients

Washington roundup: Final guidance for trial data systems tweaks draft slightly

Report from Europe: EU delays vote again regarding CE mark reform

HIT roundup: DSS to work with NY OMH to implement EHR, vxVistA

Financings roundup: Nanosphere raises about $27.7M in public offering

Agreements/contracts: Solstas to distribute Natera's prenatal test

Court report: Ivera files suit vs. Covidien alleging patent infringement

Patent watch: VeriTeQ receives 2 patents for its product portfolio

Restructuring roundup: Alphatec Spine to restructure Scient'x business operations

Product Briefs

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for June 10, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors

BioWorld Science

Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.

Wuxi Apptec insists it’s ‘not a Chinese military company’

BioWorld

Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...